Find Reports

Select Report Type

Reimbursement Review

Displaying 801 - 825 of 1258

Please scroll or swipe to the right to view the full content.

Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Zelboraf	Vemurafenib	pcodr_provfund_vemurafenib_zelboraf-advmel.pdf pcodr-zelboraf-adv-mel-fn-rec.pdf pcodr-zelboraf-unredact-fn-cgr.pdf pcodr-zelboraf-adv-mel-fn-egr.pdf pcodr-zelboraf-in-rec.pdf pcodr-zelboraf-pag-fdk-in-rec.pdf pcodr-zelboraf-in-fdk-roche.pdf pcodr-zelborafadmel-in-fdk-mnc.pdf pcodr-zelboraf-adv-mel-coi-mnc.pdf	Metastatic Melanoma	Reimburse with clinical criteria and/or conditions	Complete	Dec 6, 2011	Jun 1, 2012	PC0006-000
Gelnique	Oxybutynin Chloride Gel	cdr_tracking_Gelnique.pdf cdr_complete_Gelnique_May 28-2012.pdf	Overactive bladder	Do not list	Complete	Oct 25, 2011	May 24, 2012	SR0260-000
ASMANEX	Mometasone furoate	cdr_tracking_Asmanex.pdf cdr_complete_Asmanex_ May-16-12.pdf	Asthma	List	Complete	Nov 10, 2011	May 16, 2012	SR0258-000
Sutent	Sunitinib malate	pcodr-provfund_sutent-pnets.pdf pcodr-sutent-pnet-fn-rec.pdf pcodr-sutent-pnet-fn-cgr.pdf pcodr-sutent-pnet-fn-egr.pdf pcodr-sutent-in-rec.pdf pcodr-sutent-pnet-pag-fd-irec.pdf pcodr-sutentpnet-in-fdk-pzr.pdf pcodr-sutent-pnet-coi-cnets.pdf	Pancreatic Neuroendocrine Tumour	Reimburse with clinical criteria and/or conditions	Complete	Nov 7, 2011	May 3, 2012	PC0004-000
Ozurdex	Dexamethasone intravitreal implant	cdr_tracking_Ozurdex.pdf cdr_complete_Ozurdex_April-27-1_e.pdf	Macular edema, central retinal vein occlusion	Do not list	Complete	Sep 1, 2011	Apr 25, 2012	SR0247-000
Benlysta	Belimumab	cdr_tracking_Benlysta.pdf cdr_complete_Benlysta_April-27-12_e.pdf	Systemic lupus erythematosus	Do not list	Complete	Sep 19, 2011	Apr 25, 2012	SR0251-000
RAPAFLO	Silodosin	cdr_tracking_Rapaflo.pdf cdr_complete_Rapaflo_April-20-12.pdf	Benign prostatic hyperplasia	Do not list	Complete	Oct 25, 2011	Apr 19, 2012	SR0261-000
Xarelto	Rivaroxaban	cdr_tracking_Xarelto-SPAF_2.pdf cdr_complete_Xarelto-SPAF_April-20-12.pdf	Atrial fibrillation, stroke prevention	List with clinical criteria and/or conditions	Complete	Oct 21, 2011	Apr 19, 2012	SR0257-000
Visanne	Dienogest	cdr_tracking_Visanne.pdf cdr_complete_Visanne_April-20-12.pdf	Pain, pelvic pain associated with endometriosis	List with clinical criteria and/or conditions	Complete	Oct 18, 2011	Apr 19, 2012	SR0255-000
COMPLERA	Emtricitabine/ rilpivirine/ tenofovir disoproxil fumarate	cdr_tracking_Complera.pdf cdr_complete_Complera_April-20-12.pdf	HIV infection	List	Complete	Oct 19, 2011	Apr 19, 2012	SR0256-000
Yervoy	Ipilimumab	pcodr-provfund_yervoy-advmel.pdf pcodr-yervoy-adv-mel-fn-rec.pdf pcodr-yervoy-adv-mel-fn-cgr.pdf pcodr-yervoy-adv-mel-fn-egr.pdf pcodr-yervoy-in-rec.pdf pcodr-yervoyadvmel-pag-fd-irec.pdf pcodr-yervoyadvmel-in-fdk-bms.pdf pcodr-yervoyadvmel-in-fdk-mnc.pdf pcodr-yervoy-adv-mel-coi-mnc.pdf pcodr-yervoy-adv-mel-coi-sys.pdf	Advanced Melanoma	Reimburse with clinical criteria and/or conditions	Complete	Dec 1, 2011	Apr 18, 2012	PC0003-000
Lucentis	Ranibizumab	cdr_tracking_Lucentis.pdf cdr-complete_Lucentis_DME_March-21-12.pdf	Macular edema, diabetic	List with clinical criteria and/or conditions	Complete	Sep 14, 2011	Mar 19, 2012	SR0253-000
Banzel	Rufinamide	cdr_tracking_Banzel.pdf cdr_complete_Banzel_March-19-12_e.pdf	Lennox-Gastaut syndrome	List with clinical criteria and/or conditions	Complete	Sep 20, 2011	Mar 15, 2012	SR0252-000
Edurant	Rilpivirine	cdr_tracking_edurant.pdf cdr_complete_Edurant_Feb-17-12_e.pdf	HIV infection	List	Complete	Jul 29, 2011	Feb 15, 2012	SR0243-000
Trajenta	Linagliptin	Recommendation and Reasons: Updated Submission Status Report Recommendation and Reasons: Original	Diabetes mellitus, type 2	List with clinical criteria and/or conditions	Complete	Aug 23, 2011	Feb 15, 2012	SR0244-000
Incivek	Telaprevir	cdr_tracking_Incivek.pdf cdr_complete_Incivek_Feb-17-12_e.pdf	Hepatitis C, chronic	List with clinical criteria and/or conditions	Complete	Aug 23, 2011	Feb 15, 2012	SR0249-000
Onsolis	Fentanyl Citrate	cdr_tracking_Onsolis_2.pdf cdr_complete_Onsolis_Feb-17-12_e.pdf cdr_trans_onsolis-resub_plr_aug-13-12_e.pdf	Pain, breakthrough cancer pain	Do not list	Complete	Aug 22, 2011	Feb 15, 2012	SR0248-000
Targin	Oxycodone HCI / naloxone HCI	cdr_tracking_targin_Resub1.pdf cdr_complete_Targin_2_Jan-27-12_e.pdf	Pain, moderate to severe and relief of opioid-induced constipation	Do not list	Complete	Jul 5, 2011	Jan 25, 2012	SR0241-000
Votrient	Pazopanib hydrochloride	pcodr-provfund_votrient-mrcc.pdf pcodr-votrientmrcc-fn-rec.pdf pcodr-votrientmrcc-fn-cgr.pdf pcodr-votrientmrcc-fn-egr.pdf pcodr-votrientmrcc-initial-rec.pdf pcodr-votrientmrcc-pag-fd-irec.pdf pcodr-votrientmrcc-in-fdk-gsk.pdf pcodr-votrientmrcc-in-fdk-kcc.pdf pcodr-votrientmrcc-kcc-coi.pdf	Metastatic Renal Cell Carcinoma	Reimburse	Complete	Jul 14, 2011	Jan 5, 2012	PC0000-000
Brilinta	Ticagrelor	cdr_tracking_brilinta.pdf cdr_complete_Brilinta_Dec-20-11.pdf cdr_trans_Brilinta_plr_Aug-13-12_e.pdf	Acute coronary syndromes	Do not list	Complete	Jun 1, 2011	Dec 16, 2011	SR0234-000
Abstral	Fentanyl citrate	cdr_tracking_abstral.pdf cdr_complete_Abstral_Dec-20-11.pdf cdr_trans_Abstral_PLR_July-3-12.pdf	Pain, breakthrough cancer pain	Do not list	Complete	Jun 30, 2011	Dec 16, 2011	SR0240-000
Twynsta	Telmisartan/ Amlodipine	cdr_tracking_Twynsta_2.pdf cdr_complete_Twynsta_Dec-20-11.pdf cdr_trans_Twynsta_plr_June-15-12.pdf	Hypertension	List	Complete	Aug 23, 2011	Dec 16, 2011	SR0245-000
Gilenya	Fingolimod	cdr_tracking_gilenya.pdf cdr_complete_Gilenya_Nov-18-11_e.pdf cdr_trans_Gilenya_plr_Mar-1-12.pdf	Multiple Sclerosis, relapsing-remitting	List with clinical criteria and/or conditions	Complete	May 10, 2011	Nov 16, 2011	SR0228-000
XGEVA	Denosumab	cdr_tracking_XGEVA-Pilot.pdf cdr_complete_Xgeva_Nov-18-11_e.pdf cdr_trans_Xgeva_plr_Mar-8-12.pdf	Prevention of skeletal-related events due to bone metastases from solid tumours	List with clinical criteria and/or conditions	Complete	Jun 6, 2011	Nov 16, 2011	SR0235-000
Aclasta	Zoledronic acid	cdr_tracking_aclasta_request-advice.pdf cdr_complete_Aclasta-RFA_Nov-18-11_e.pdf cdr_trans_Aclasta_RfA_PLR_April 4-2012.pdf	Osteoporosis	List with clinical criteria and/or conditions	Complete	Jul 20, 2011	Nov 16, 2011	SF0242-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 801 - 825 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
CADTH and the Canadian Institute for Health Information (CIHI) Real-World Evidence Feasibility Collaboration	CIHI (PPD001) - GLP1 for feedback.pdf	Jun 1, 2022	Health Technology Review	Technology Review	Completed	CP0027 - HC0019
Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Refractory or High-Risk Patients	Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Refracto…	May 31, 2022	Health Technology Review	Rapid Review	Completed	RC1430-000
bimekizumab	Recommendation and Reasons: Updated Recommendation and Reasons: Original Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	May 31, 2022	Reimbursement Review		Complete	SR0698-000
Stepped Care Models for Chronic Pain	Stepped Care Models for Chronic Pain	May 30, 2022	Health Technology Review	Technology Review	Completed	HC0034-000
Reconsolidation and Consolidation Therapies for the Treatment and Prevention of Post-Traumatic Stress Disorder	Reconsolidation and Consolidation Therapies for the Treatment and Prevention of…	May 26, 2022	Health Technology Review	Rapid Review	Completed	RC1424-000
enfortumab vedotin	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Stakeholder feedback on Draft Recommendation	May 26, 2022	Reimbursement Review		Complete	PC0251-000
Multiple myeloma	Multiple myeloma - Final Report	May 25, 2022	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0011-000
An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devices	An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devi…	May 24, 2022	Horizon Scan	Emerging Health Technologies	Completed	EH0102-000
Robotic-Assisted Spinal Surgery	Robotic-Assisted Spinal Surgery	May 24, 2022	Health Technology Review	Rapid Review		RC1427-000
Melatonin for the Treatment of Insomnia: A 2022 Update	Melatonin for the Treatment of Insomnia: A 2022 Update	May 24, 2022	Health Technology Review	Rapid Review	Completed	RC1422-000
Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer	Final Report	May 24, 2022	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0009-000
Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Detachment Surgery	Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following…	May 20, 2022	Health Technology Review	Rapid Review		RC1428-000
Pre-Surgical Screening Tools and Risk Factors for Chronic Post-Surgical Pain	Pre-Surgical Screening Tools and Risk Factors for Chronic Post-Surgical Pain	May 17, 2022	Health Technology Review	Technology Review	Completed	HC0023-000
dinutuximab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Clinician Input Stakeholder feedback on Draft Recommendation	May 17, 2022	Reimbursement Review		Complete	PC0222-000
Melatonin for the Treatment or Prevention of Delirium	Melatonin for the Treatment or Prevention of Delirium	May 17, 2022	Health Technology Review	Rapid Review	Completed	RC1421-000
An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease	An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer D…	May 16, 2022	Horizon Scan	Emerging Health Technologies	Completed	EH0103-000
daratumumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Clinician Input Stakeholder feedback on Draft Recommendation	May 16, 2022	Reimbursement Review		Complete	PC0257-000
Clinical Effectiveness of Second Generation Injectable Antipsychotics	Clinical Effectiveness of Second Generation Injectable Antipsychotics	May 12, 2022	Health Technology Review	Rapid Review	Completed	RC1418-000
somatrogon	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder Feedback on Draft Recommendation	May 11, 2022	Reimbursement Review		Complete	SR0683-000
Cost-Effectiveness of Treatment for Pediatric Immune Thrombocytopenia	Cost-Effectiveness of Treatment for Pediatric Immune Thrombocytopenia	May 5, 2022	Health Technology Review	Rapid Review	Completed	RC1425-000
fedratinib	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Stakeholder feedback on Draft Recommendation Clinician Input	May 5, 2022	Reimbursement Review		Complete	PC0205-000
pembrolizumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submission Clinician Input Stakeholder feedback on Draft Recommendation	May 4, 2022	Reimbursement Review		Complete	PC0235-000
Management of HIV in Primary Care Settings	Management of HIV in Primary Care Settings	May 4, 2022	Health Technology Review	Technology Review	Completed	HC0028-000
isatuximab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Patient Group Input Submissions Stakeholder feedback on Draft Recommendation	May 2, 2022	Reimbursement Review		Complete	PC0256-000
Hub-and-Spoke Models of Care for Chronic Pain	Hub-and-Spoke Models of Care for Chronic Pain	May 2, 2022	Health Technology Review	Technology Review	Completed	HC0030-000